Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-097597
Filing Date
2024-11-13
Accepted
2024-11-13 17:17:40
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0220242-10q_bespoke.htm   iXBRL 10-Q 511804
2 CERTIFICATION ea022024201ex31-1_bespoke.htm EX-31.1 11757
3 CERTIFICATION ea022024201ex32-1_bespoke.htm EX-32.1 4431
  Complete submission text file 0001213900-24-097597.txt   4224639

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20240930.xsd EX-101.SCH 39205
5 XBRL CALCULATION FILE bspk-20240930_cal.xml EX-101.CAL 33161
6 XBRL DEFINITION FILE bspk-20240930_def.xml EX-101.DEF 252604
7 XBRL LABEL FILE bspk-20240930_lab.xml EX-101.LAB 410851
8 XBRL PRESENTATION FILE bspk-20240930_pre.xml EX-101.PRE 254305
61 EXTRACTED XBRL INSTANCE DOCUMENT ea0220242-10q_bespoke_htm.xml XML 332272
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

EIN.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 241455696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)